Other featured articles

• Women and Adolescent Girls Face Barriers Accessing Contraceptives – Even in Blue States Like California

  States dedicated to ensuring women receive the care they need should fix existing gaps in contraceptive access.

  By Dima M. Qato, PharmD, MPH, PhD

  Posted in

  Evidence Base > Hospitals and Health Systems
• It’s Time to Let Pharmacists Prescribe COVID-Fighting Pills Like Paxlovid

  To reduce hospitalization and death, pharmacists should have the same prescribing abilities as doctors for COVID anti-viral drugs Paxlovid and Lagevrio, USC School of Pharmacy
  Dean Vassilios Papadopoulos writes in a new MarketWatch op-ed.

  By Vassilios Papadopoulos, DPharm, PhD, DSc (hon)

  Posted in

  Perspective > Patient and Physician Behavior
• The Unequal Causes and Costs of Dementia

  Dementia and its costs aren’t equally borne by all populations. Studies indicate that, compared to older non-Hispanic white adults, older Black adults are about twice as likely to have dementia, and older Hispanic adults about one and one-half times as likely.

  By Johanna Thunell, PhD and Julie Zissimopoulos, PhD

  Posted in

  Evidence Base > Alzheimer's Disease and Dementia
• U.S. Consumers Overpay for Generic Drugs

  Tactics used by intermediaries in the pharmaceutical distribution system, including pharmacy benefit managers (PBMs) and insurers, are costing patients, employers and the government billions for what should be inexpensive medicines.

  Posted in

  White Paper > Drug pricing